Thomas Jefferson University Hospitals

News

Nanotherapeutic targets tumors in lung cancer patients, saves healthy cells

A French nanomedicine company developing a novel cancer therapeutic to strategically destroy tumors in lung cancer patients to improve survival rates has forged a research collaboration with an East Coast hospital. Nanobiotix’s two-year research collaboration is with Thomas Jefferson University Hospitals in Philadelphia, the only U.S. hospital conducting a preclinical trial with nanoXray therapeutics, said […]